GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » 5-Year Yield-on-Cost %

ME Therapeutics Holding (FRA:Q9T) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 12, 2025)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding 5-Year Yield-on-Cost %?

ME Therapeutics Holding's yield on cost for the quarter that ended in Nov. 2024 was 0.00.


The historical rank and industry rank for ME Therapeutics Holding's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:Q9T's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.74
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of ME Therapeutics Holding's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, ME Therapeutics Holding's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ME Therapeutics Holding's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's 5-Year Yield-on-Cost % falls into.


;
;

ME Therapeutics Holding 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of ME Therapeutics Holding is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

ME Therapeutics Holding  (FRA:Q9T) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


ME Therapeutics Holding 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding Business Description

Traded in Other Exchanges
Address
177 Robson St., Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines